Clinical trial
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post…
NCT00004817 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00004817 |
|---|---|
| Title | Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Collaborators | Harborview Injury Prevention and Research Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post-Traumatic Seizure Disorder, Head Injuries |
| Intervention type | Drug |
| Interventions | phenytoin, valproate sodium |
| Enrollment | 385 |
| Start date | Feb 1, 1991 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: